Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations

被引:25
作者
Leuzzi, V
Rinalduzzi, S
Chiarotti, F
Garzia, P
Trasimeni, G
Accornero, N
机构
[1] Dipartimento Sci Neurol & Psichiat Eta Evolut, Rome, Italy
[2] Univ Rome La Sapienza, Dipartimento Sci Neurol, I-00185 Rome, Italy
[3] Ist Super Sanita, I-00161 Rome, Italy
[4] Univ Rome La Sapienza, Div Prima Clin Med Gen & Terapia, Serv TC RMN, Rome, Italy
关键词
D O I
10.1023/A:1005346422918
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
During detailed visual function testing, pattern-reversal visual evoked potentials (VEP), generated by different spatial frequencies (3 c/d, 1 c/d and 0.6 c/d) and visual contrasts (100% and 10%) were recorded in 21 adolescent and young adult phenylketonuric (PKU) patients (11 females and 10 males; mean age 14.8 years, range 9-22.8) on and off diet. In 14 of the 21 patients, disease had been detected at neonatal screening and in 7 later. Ten age-matched healthy subjects acted as controls. Recordings in more than 40% of eyes in the whole group and 30% of eyes in the screening subgroup showed a prolonged P100 latency. All visual pattern stimuli elicited a significantly longer P100 latency in PKU patients than in controls. VEP latencies to 3 c/d, 1 c/d and 1 c/d with 10% contrast - but not to 0.6 c/d - were longer in patients off diet than in patients on diet. No differences were found between VEP latencies in early- and later-detected subjects. To study the link between biochemical variables and VEP latencies, we envisaged either a linear relationship between recent exposure to phenylalanine (Phe) and VEP abnormalities or a threshold model considering phenylalanine (Phe) concentrations among the factors influencing VEP latencies. The correlation analysis detected an association between plasma Phe concentrations and abnormal VEP latencies, predicting that plasma Phe concentrations >901 mu mol/L would prolong VEP latencies to 1c/d; concentrations >879 mu mol/L would prolong latencies to 3c/d; and concentrations > 898 mu mol/L would prolong latencies to 1 c/d with 10% contrast. Finally, our data confirmed a lack of correlation between white-matter abnormalities on MRI and abnormal VEP latencies. Our findings suggest that in young patients with PKU, prolonged, late exposure to high plasma Phe concentrations induces subclinical visual dysfunction. Although our findings do not allow us to specify the origin of visual system changes in PKU, they favour impairment of the retinal loop as the responsible mechanism.
引用
收藏
页码:351 / 364
页数:14
相关论文
共 45 条
[1]   COLOR VEPS IN PARKINSONS-DISEASE [J].
BARBATO, L ;
RINALDUZZI, S ;
LAURENTI, M ;
RUGGIERI, S ;
ACCORNERO, N .
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1994, 92 (02) :169-172
[2]   EFFECT OF L-DOPA ON VISUAL EVOKED-POTENTIAL IN PATIENTS WITH PARKINSONS-DISEASE [J].
BHASKAR, PA ;
VANCHILINGAM, S ;
BHASKAR, EA ;
DEVAPRABHU, A ;
GANESAN, RA .
NEUROLOGY, 1986, 36 (08) :1119-1121
[3]   DISTURBED MYELINATION IN PATIENTS WITH TREATED HYPERPHENYLALANINEMIA - EVALUATION WITH MAGNETIC-RESONANCE-IMAGING [J].
BICK, U ;
FAHRENDORF, G ;
LUDOLPH, AC ;
VASSALLO, P ;
WEGLAGE, J ;
ULLRICH, K .
EUROPEAN JOURNAL OF PEDIATRICS, 1991, 150 (03) :185-189
[4]   VISUAL DYSFUNCTION IN PARKINSONS-DISEASE - LOSS IN SPATIOTEMPORAL CONTRAST SENSITIVITY [J].
BODISWOLLNER, I ;
MARX, MS ;
MITRA, S ;
BOBAK, P ;
MYLIN, L ;
YAHR, M .
BRAIN, 1987, 110 :1675-1698
[5]   VISUAL DEFICITS RELATED TO DOPAMINE DEFICIENCY IN EXPERIMENTAL-ANIMALS AND PARKINSONS-DISEASE PATIENTS [J].
BODISWOLLNER, I .
TRENDS IN NEUROSCIENCES, 1990, 13 (07) :296-302
[6]   DOPAMINERGIC DEFICIENCY AND DELAYED VISUAL EVOKED-POTENTIALS IN HUMANS [J].
BODISWOLLNER, I ;
YAHR, MD ;
MYLIN, L ;
THORNTON, J .
ANNALS OF NEUROLOGY, 1982, 11 (05) :478-483
[7]  
BODISWOLLNER I, 1982, ARCH NEUROL-CHICAGO, V39, P284
[8]   EFFECT OF LEVODOPA TREATMENT ON CONTRAST SENSITIVITY IN PARKINSONS-DISEASE [J].
BULENS, C ;
MEERWALDT, JD ;
VANDERWILDT, GJ ;
VANDEURSEN, JBP .
ANNALS OF NEUROLOGY, 1987, 22 (03) :365-369
[9]   CONTRAST SENSITIVITY IN PARKINSONS-DISEASE [J].
BULENS, C ;
MEERWALDT, JD ;
VANDERWILDT, GJ ;
KEEMINK, CJ .
NEUROLOGY, 1986, 36 (08) :1121-1125
[10]   THE DEVELOPMENT OF AUDITORY AND VISUAL EVOKED-POTENTIALS IN EARLY TREATED PHENYLKETONURIC CHILDREN [J].
CARDONA, F ;
LEUZZI, V ;
ANTONOZZI, I ;
BENEDETTI, P ;
LOIZZO, A .
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1991, 80 (01) :8-15